Roy Vergis

454 total citations
6 papers, 300 citations indexed

About

Roy Vergis is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Roy Vergis has authored 6 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Roy Vergis's work include Prostate Cancer Treatment and Research (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Roy Vergis is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). Roy Vergis collaborates with scholars based in United Kingdom and Denmark. Roy Vergis's co-authors include Matthew R. Sydes, David P. Dearnaley, Vincent Khoo, Chris Parker, Rosalind A. Eeles, Alan Horwich, Robert Huddart, Catherine M. Corbishley, Michael Borre and Sameer Jhavar and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Roy Vergis

5 papers receiving 298 citations

Peers

Roy Vergis
Roy Vergis
Citations per year, relative to Roy Vergis Roy Vergis (= 1×) peers Molykutty John‐Aryankalayil

Countries citing papers authored by Roy Vergis

Since Specialization
Citations

This map shows the geographic impact of Roy Vergis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Vergis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Vergis more than expected).

Fields of papers citing papers by Roy Vergis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Vergis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Vergis. The network helps show where Roy Vergis may publish in the future.

Co-authorship network of co-authors of Roy Vergis

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Vergis. A scholar is included among the top collaborators of Roy Vergis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Vergis. Roy Vergis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Mir, Rashid, et al.. (2017). Cumulative corticosteroid exposure in patients experiencing checkpoint inhibitor toxicity.. Journal of Clinical Oncology. 35(15_suppl). e21010–e21010. 2 indexed citations
2.
Reid, Alison, Gerhardt Attard, Daniel Brewer, et al.. (2012). Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer. Modern Pathology. 25(6). 902–910. 35 indexed citations
3.
Vergis, Roy, Catherine M. Corbishley, Karen Thomas, et al.. (2010). Expression of Bcl-2, p53, and MDM2 in Localized Prostate Cancer With Respect to the Outcome of Radical Radiotherapy Dose Escalation. International Journal of Radiation Oncology*Biology*Physics. 78(1). 35–41. 25 indexed citations
4.
McCarthy, Frank, Ashley A. Fletcher, Nening M. Dennis, et al.. (2009). An improved method for constructing tissue microarrays from prostate needle biopsy specimens. Journal of Clinical Pathology. 62(8). 694–698. 9 indexed citations
5.
McVey, G., Scott C. Morgan, Roy Vergis, et al.. (2009). Benefit of radiotherapy dose escalation in localized prostate cancer with respect to expression of intrinsic markers of hypoxia. Journal of Clinical Oncology. 27(15_suppl). e16068–e16068.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026